Back

Pre-Clinical Evaluation of a Novel Immunomodulator: a potential immunotherapy for coronaviral disease

Lee, I.; Desai, A.; Berdis, A. J.; Patil, A.; Xu, Y.; Pozza-Adams, K.

2025-04-02 cell biology
10.1101/2025.04.01.646433 bioRxiv
Show abstract

At present, no unifying animal study to quantify the effect of PI on innate immunity in animals has been reported. This study quantifies the effect of PI in mice and THP-1 cells using a multi-disciplinary approach employing flow cytometry to measure immune function and mass spectroscopy to identify metabolomic profiles of treated cells. For proof of principle, a case study was conducted to examine the potential benefit of administering PI to improve outcomes of a feline leukemia-positive cat that also contracted the effusive form of FIP. Our results indicate that quantifiable cellular and metabolic markers result from PI treatment and can be used to establish a platform measuring the efficacy of PI in modulating the innate immune system.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Metabolites
○ 53 papers in training set
Top 0.1%
16.1%
Similar papers in this journal
2
PLOS ONE
● 5266 papers in training set
Top 19%
9.5%
Similar papers in this journal
3
Scientific Reports
○ 3612 papers in training set
Top 5%
8.4%
Similar papers in this journal
4
Frontiers in Pharmacology
○ 111 papers in training set
Top 0.4%
5.2%
Similar papers in this journal
5
Journal of Proteome Research
● 234 papers in training set
Top 0.8%
3.5%
Similar papers in this journal
6
Analytical Chemistry
● 218 papers in training set
Top 1%
2.3%
7
Pharmaceutics
○ 24 papers in training set
Top 0.2%
2.3%
8
Biomolecules
○ 100 papers in training set
Top 0.9%
1.8%
9
International Journal of Molecular Sciences
○ 494 papers in training set
Top 7%
1.8%
50% of probability mass above
10
Communications Biology
○ 993 papers in training set
Top 13%
1.8%
11
Clinical and Translational Medicine
○ 31 papers in training set
Top 0.3%
1.8%
12
The FASEB Journal
○ 194 papers in training set
Top 3%
1.6%
13
Cancers
○ 213 papers in training set
Top 4%
1.2%
14
ACS Pharmacology & Translational Science
● 40 papers in training set
Top 0.5%
1.2%
15
eLife
● 5828 papers in training set
Top 57%
1.2%
16
Viruses
○ 332 papers in training set
Top 4%
1.1%
17
Journal of Lipid Research
○ 39 papers in training set
Top 0.4%
1.1%
18
Data in Brief
○ 14 papers in training set
Top 0.1%
1.1%
19
iScience
○ 1154 papers in training set
Top 29%
1.1%
20
ACS Infectious Diseases
● 82 papers in training set
Top 1%
1.1%
21
Microbiology Spectrum
● 469 papers in training set
Top 9%
1.0%
22
Cell Reports Medicine
○ 153 papers in training set
Top 4%
1.0%
23
Biomedicine & Pharmacotherapy
○ 42 papers in training set
Top 1%
0.9%
24
SLAS Discovery
○ 25 papers in training set
Top 0.3%
0.9%
25
ACS Omega
● 105 papers in training set
Top 3%
0.9%
26
Journal of Medicinal Chemistry
● 77 papers in training set
Top 0.8%
0.9%
27
Scientific Data
○ 209 papers in training set
Top 2%
0.9%
28
The Journal of Pharmacology and Experimental Therapeutics
○ 18 papers in training set
Top 0.4%
0.9%
29
Metabolomics
○ 14 papers in training set
Top 0.2%
0.9%
30
Journal of Clinical Investigation
● 179 papers in training set
Top 5%
0.9%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.